We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Calamp Corp
12 own
17 watching
Current Price
$6.9
$-0.68
(-8.97%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
9.28M
52-Week High
12.30000
52-Week Low
0.020099999
Average Volume
0.07M
Dividend Yield
--
P/E Ratio
216.47
Market Capitalization9.28M52-Week High12.3000052-Week Low0.020099999Average Volume0.07MDividend Yield--P/E Ratio216.47What does the Calamp Corp do?
CAMP4 Therapeutics Corporation is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics with the goal of upregulating gene expression and restoring healthy protein levels to treat a broad range of genetic diseases. It is leveraging its RAP Platform to advance a pipeline of programs initially focused on metabolic and central nervous system (CNS) disorders with validated disease biology and potential market opportunities due to the significant unmet need of affected patients. Its lead product candidate, CMP-CPS-001, has the potential to be the first disease-modifying therapy for the treatment of urea cycle disorders. CMP-CPS-001 is designed to improve urea cycle activity by amplifying expression of CPS1, a key enzyme that catalyzes the first step of the urea cycle, by binding to a CPS1-specific regRNA. Its CNS development program, CMP-SYNGAP, is focused on addressing the underlying cause of SYNGAP1-related disorders.
Read More
How much money does Calamp Corp make?
News & Events about Calamp Corp.
Globe Newswire
1 year ago
IRVINE, Calif., Jan. 27, 2023 (GLOBE NEWSWIRE) -- CalAmp (Nasdaq: CAMP), a connected intelligence company that helps people and organizations improve operational performance, today announced that it initiated a restructuring plan to reduce approximately eight percent of its employees across various ...
Zolmax
2years ago
CalAmp Corp. (NASDAQ:CAMP Get Rating) Director Wes Cummins acquired 60,000 shares of CalAmp stock in a transaction that occurred on Wednesday, October 12th. The stock was bought at an average price of $3.38 per share, with a total value of $202,800.00. Following the purchase, the director now ...
Market News Video
2years ago
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So lets look at two noteworthy recent insider buys...
Ticker Report
2years ago
Shares of CalAmp Corp. (NASDAQ:CAMP Get Rating) have received an average recommendation of Buy from the six research firms that are currently covering the company, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold rating and three have ...
Frequently Asked Questions
Frequently Asked Questions
What is Calamp Corp share price today?
Can Indians buy Calamp Corp shares?
How can I buy Calamp Corp shares from India?
Can Fractional shares of Calamp Corp be purchased?
What are the documents required to start investing in Calamp Corp stocks?
What is today’s traded volume of Calamp Corp?
What is today’s market capitalisation of Calamp Corp?
What is the 52-Week High and Low Range of Calamp Corp?
What percentage is Calamp Corp down from its 52-Week High?
What percentage is Calamp Corp up from its 52-Week Low?
Current Price
$6.9
$-0.68
(-8.97%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.